EP News Bureau

Cipla launches remdesivir under brand name CIPREMI

Read more

Hetero announces launch of generic remdesivir ‘COVIFOR’ for COVID-19 treatment

Read more

Cipla, Hetero get DCGI nod to manufacture remdesivir

Read more

India: A global nutraceutical hub in the making

Read more

Acute myeloid leukaemia market to reach $5.1 billion by 2029: GlobalData

Read more

Piramal Pharma to acquire manufacturing facility from G&W Laboratories in the US

Read more

Network of channels inside bacterial communities can help kill bacteria faster: Study

Read more

MIS-C research can give insights on COVID-19 effect on immune system

Read more

US FDA grants approval to Ultragenyx Pharmaceutical for Crysvita

Read more

Dr Reddy’s Laboratories launch Abiraterone Acetate Tablets USP in the US

Read more